Solos Endoscopy’s sales increased to just under $98,000 for the period ended March 31, up from about $84,000 for the same period last year.
Management of the company said it expects the increase in sales to continue as global demand for endoscopic instruments increases.
“I am very pleased with the positive turnaround,” said Bob Segersten, president of Solos Endoscopy, in the release. “Solos has been able to reduce its debts and increase its sales in a very short period of time. We believe the company is well positioned for profitability.”
Related Articles on Solos Endoscopy:
Solos Endoscopy to Launch New Endoscopic Instrument Line
Solos Endoscopy Credits Orders for MammoView, Vascular Clamps for Increased Revenues
Solos Endoscopy Completes Capital Restructuring Initiatives
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
